US paus­es dis­tri­b­u­tion of GSK/Vir's Covid mAb not due to Omi­cron, but greater sup­ply of Eli Lil­ly mAbs

The US gov­ern­ment is shift­ing its dis­tri­b­u­tion of mAb in­fu­sions to fight the coro­n­avirus, de­cid­ing to go from sup­ply­ing tens of …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.